Structural and functional abnormalities in iron-depleted heart.

Authors:
Kobak KA; Radwańska M; Dzięgała M; Kasztura M; Josiak K and 3 more

Journal:
Heart Fail Rev

Publication Year: 2019

DOI:
10.1007/s10741-018-9738-4

PMCID:
PMC6394598

PMID:
30284070

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Heart Fail Rev

Abbreviation: Heart Fail Rev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
ACEI/ARB and beta-blocker therapies for preventing cardiotoxicity of antineoplastic agents in breas…
Gao Y; Wang R; Jiang J and 3 more (2023) - Transparency Score: 3/6
Acute advanced aortic stenosis.
Avvedimento M; Angellotti D; Ilardi F and 11 more (2023) - Transparency Score: 3/6
Advance of echocardiography in cardiac amyloidosis.
Liang S; Liu Z; Li Q and 2 more (2023) - Transparency Score: 2/6
Artificial intelligence models in prediction of response to cardiac resynchronization therapy: a sy…
Nazar W; Szymanowicz S; Nazar K and 4 more (2023) - Transparency Score: 3/6
Effectiveness of mobile telemonitoring applications in heart failure patients: systematic review of…
Rebolledo Del Toro M; Herrera Leaño NM; Barahona-Correa JE and 3 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest Wrocław Medical University received an unrestricted grant from Vifor Pharma outside the submitted work. Monika Kasztura reports financial support from Vifor Pharma for travel and accommodation for scientific meeting. Waldemar Banasiak reports personal fees from Vifor Pharma, outside the submitted work. Piotr Ponikowski reports personal fees from Vifor Pharma and personal fees from AMGEN, outside the submitted work. Ewa A. Jankowska reports personal fees from Vifor Pharma and FRESENIUS, outside the submitted work."

Evidence found in paper:

"Funding information The present study was financially supported by the National Science Centre (Kraków, Poland; grant no. 2014/13/B/NZ5/03146)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025